RhumbLine Advisers’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,487
| Closed | -$13.9K | – | 4358 |
|
|
2024
Q2 | $13.9K | Sell |
9,487
-15,899
| -63% | -$23.2K | ﹤0.01% | 3933 |
|
|
2024
Q1 | $59.4K | Buy |
25,386
+589
| +2% | +$1.38K | ﹤0.01% | 3591 |
|
|
2023
Q4 | $50.1K | Hold |
24,797
| – | – | ﹤0.01% | 3633 |
|
|
2023
Q3 | $120K | Buy |
24,797
+1,249
| +5% | +$6.05K | ﹤0.01% | 3396 |
|
|
2023
Q2 | $161K | Buy |
23,548
+4,245
| +22% | +$29K | ﹤0.01% | 3345 |
|
|
2023
Q1 | $140K | Buy |
19,303
+814
| +4% | +$5.9K | ﹤0.01% | 2812 |
|
|
2022
Q4 | $237K | Buy |
18,489
+424
| +2% | +$5.44K | ﹤0.01% | 2748 |
|
|
2022
Q3 | $255K | Buy |
18,065
+1,069
| +6% | +$15.1K | ﹤0.01% | 2802 |
|
|
2022
Q2 | $209K | Buy |
+16,996
| New | +$209K | ﹤0.01% | 2914 |
|